Zysis is a pharmaceutical company optimising therapies for disorders of the Central Nervous System to improve sufferers’ lives. The company is currently developing a new drug for the treatment of psychotic conditions, having reformulated an effective anti-psychotic compound to create a controlled release, once-weekly, oral maintenance phase therapy.